BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8875766)

  • 1. Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia: significance of acetylcarnitine determination to estimate the proper carnitine dose.
    Itoh T; Ito T; Ohba S; Sugiyama N; Mizuguchi K; Yamaguchi S; Kidouchi K
    Tohoku J Exp Med; 1996 Jun; 179(2):101-9. PubMed ID: 8875766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isovaleric acidemia: response to a leucine load after three weeks of supplementation with glycine, L-carnitine, and combined glycine-carnitine therapy.
    Fries MH; Rinaldo P; Schmidt-Sommerfeld E; Jurecki E; Packman S
    J Pediatr; 1996 Sep; 129(3):449-52. PubMed ID: 8804338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-carnitine therapy in isovaleric acidemia.
    Roe CR; Millington DS; Maltby DA; Kahler SG; Bohan TP
    J Clin Invest; 1984 Dec; 74(6):2290-5. PubMed ID: 6549017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to L-carnitine and glycine therapy in isovaleric acidaemia.
    de Sousa C; Chalmers RA; Stacey TE; Tracey BM; Weaver CM; Bradley D
    Eur J Pediatr; 1986 Feb; 144(5):451-6. PubMed ID: 3956533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.
    Van Hove JL; Kahler SG; Millington DS; Roe DS; Chace DH; Heales SJ; Roe CR
    Pediatr Res; 1994 Jan; 35(1):96-101. PubMed ID: 8134205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isovaleric acidemia: Therapeutic response to supplementation with glycine, l-carnitine, or both in combination and a 10-year follow-up case study.
    Chinen Y; Nakamura S; Tamashiro K; Sakamoto O; Tashiro K; Inokuchi T; Nakanishi K
    Mol Genet Metab Rep; 2017 Jun; 11():2-5. PubMed ID: 30547004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isovaleric acidemia diagnosed promptly by tandem mass spectrometry: report of one case.
    Wei CC; Lin WD; Tsai FJ; Wu JY; Peng CT; Tsai CH
    Acta Paediatr Taiwan; 2004; 45(4):236-8. PubMed ID: 15624372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term L-carnitine treatment in isovaleric acidemia.
    Mayatepek E; Kurczynski TW; Hoppel CL
    Pediatr Neurol; 1991; 7(2):137-40. PubMed ID: 2059255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-carnitine and glycine therapy in isovaleric acidaemia.
    Chalmers RA; de Sousa C; Tracey BM; Stacey TE; Weaver C; Bradley D
    J Inherit Metab Dis; 1985; 8 Suppl 2():141-2. PubMed ID: 3930869
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of isovaleric acidemia with glycine supplement.
    Naglak M; Salvo R; Madsen K; Dembure P; Elsas L
    Pediatr Res; 1988 Jul; 24(1):9-13. PubMed ID: 3137519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal handling of carnitine in secondary carnitine deficiency disorders.
    Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
    Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in exercise tolerance in isovaleric acidaemia with L-carnitine therapy.
    Lee PJ; Harrison EL; Jones MG; Chalmers RA; Leonard JV; Whipp BJ
    J Inherit Metab Dis; 1998 Apr; 21(2):136-40. PubMed ID: 9584264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric analysis of glycine conjugates and urinary isovalerylglycine in isovaleric acidemia.
    Ito T; Kidouchi K; Sugiyama N; Kajita M; Chiba T; Niwa T; Wada Y
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):317-22. PubMed ID: 8548022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and phenotype characterization in a Spanish cohort with isovaleric acidemia.
    Couce ML; Aldamiz-Echevarría L; Bueno MA; Barros P; Belanger-Quintana A; Blasco J; García-Silva MT; Márquez-Armenteros AM; Vitoria I; Vives I; Navarrete R; Fernández-Marmiesse A; Pérez B; Pérez-Cerdá C
    J Hum Genet; 2017 Mar; 62(3):355-360. PubMed ID: 27904153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of erythrocyte calpain in glycine- and carnitine-treated isovaleric acidemia.
    Salamino F; Di Lisa F; Burlina AB; Menabŏ R; Barbato R; De Tullio R; Siliprandi N
    Pediatr Res; 1994 Aug; 36(2):182-6. PubMed ID: 7970932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of carnitine and specific acylcarnitines by high-performance liquid chromatography: application to normal human urine and urine from patients with methylmalonic aciduria, isovaleric acidemia or medium-chain acyl-CoA dehydrogenase deficiency.
    Minkler PE; Hoppel CL
    J Chromatogr; 1993 Apr; 613(2):203-21. PubMed ID: 8491807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine therapy in isovaleric acidemia.
    Yudkoff M; Cohn RM; Puschak R; Rothman R; Segal S
    J Pediatr; 1978 May; 92(5):813-7. PubMed ID: 641635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carnitine deficiency in inborn errors of metabolism].
    Sela BA; Lerman-Sagie T; Berkovitz M
    Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.